Verified Nov 2026
Metal Fabrication
·
Santa Clara, California
·
Since 2008
SI-BONE is a medical device company headquartered in Santa Clara, California, founded in 2008 by Dr. Mark A. Reiley and Jeffrey W. Dunn. It employs roughly 200 to 500 people and has an estimated revenue band of $100 to $250 million. The company is publicly traded on NASDAQ under the ticker SIBN. It makes minimally invasive surgical implants for sacropelvic and musculoskeletal conditions, serving the medical industry. In September 2026, it received FDA 510(k) clearance for its iFuse Granite Onyx™ system, extending its compromised bone product line beyond the pelvis.
Si-Bone at a glance
Revenue
$100-250M
Est. band
Employees
200-500
Founded
2008
Headquarters
Santa Clara, California
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
SI-BONE is a medical device company headquartered in Santa Clara, California, founded in 2008 by Dr. Mark A. Reiley and Jeffrey W. Dunn. It employs roughly 200 to 500 people and has an estimated revenue band of $100 to $250 million. The company is publicly traded on NASDAQ under the ticker SIBN. It makes minimally invasive surgical implants for sacropelvic and musculoskeletal conditions, serving the medical industry. In September 2026, it received FDA 510(k) clearance for its iFuse Granite Onyx™ system, extending its compromised bone product line beyond the pelvis.
At a glance
Attribute | Detail |
|---|---|
Founded | 2008 |
Headquarters | Santa Clara, California |
Employees | 200-500 |
Revenue | $100-250M (estimated) |
Primary capability | Metal Fabrication |
What Si-Bone makes
The company's product line includes the iFuse Implant System for sacroiliac joint fusion, along with the iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite implants, and the newly cleared iFuse Granite Onyx system.
Latest developments
2026-11-02 — SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue Guidance | SI-BONE, Inc. (si-bone.com)
2026-09-28 — SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis | SI-BONE, Inc. (si-bone.com)
2026-08-03 — SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance | SI-BONE, Inc. (si-bone.com)
2026-05-11 — SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance | SI-BONE, Inc. (si-bone.com)
2026-02-23 — SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance | SI-BONE, Inc. (si-bone.com)
Company details
SI-BONE is listed on NASDAQ under the ticker SIBN and has reported performing over 100,000 procedures with its technologies. Si-Bone was founded in 2008, has an estimated 200-500 employees, and is headquartered in Santa Clara, California.
Frequently asked questions
What does Si-Bone make?
SI-BONE is a medical device company headquartered in Santa Clara, California, founded in 2008 by Dr. Mark A. Reiley and Jeffrey W. Dunn. It employs roughly 200 to 500 people and has an estimated revenue band of $100 to $250 million. The company is publicly traded on NASDAQ under the ticker SIBN. It makes minimally invasive surgical implants for sacropelvic and musculoskeletal conditions, serving the medical industry. In September 2026, it received FDA 510(k) clearance for its iFuse Granite Onyx™ system, extending its compromised bone product line beyond the pelvis.
Where is Si-Bone headquartered?
Si-Bone is headquartered in Santa Clara, California (471 El Camino Real, Santa Clara, California, 95050).
When was Si-Bone founded?
Si-Bone was founded in 2008.
How big is Si-Bone?
Si-Bone has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.